Published date: Aug 09 2022

Journal Title: Journal of Ophthalmic and Vision Research

Issue title: July–Sep 2022, Volume 17, Issue 3

Pages: 437 – 442

DOI: 10.18502/jovr.v17i3.11584

Chaitra Jayadevdrchaitra@hotmail.comDepartment of Vitreoretina, Narayana Nethralaya Eye Institute, Bangalore, India

Ishank GuptaDepartment of Vitreoretina, Narayana Nethralaya Eye Institute, Bangalore, India

Santosh Gopi Krishna GaddeDepartment of Vitreoretina, Narayana Nethralaya Eye Institute, Bangalore, India

Purpose: To report a case of bilateral refractory macular edema in a diabetic macular edema in a diabetic with an underlying systemic illness. Case Report: A 65-year-old male presented with the symptom of blurred vision in both eyes for three months. He was a known diabetic patient and was also hypertensive for the last 10 years. The corrected distance visual acuity was 20/120 in the right eye and 20/80 in the left eye. Fundus examination revealed multiple deep and superficial retinal hemorrhages, cystoid macular edema, and serous macular detachment in both eyes. With a diagnosis of diabetic macular edema in both eyes, the patient was treated with multiple intravitreal injections of anti-vascular endothelial growth factor and steroids. Since he did not show a favorable response, the patient was further investigated and diagnosed with multiple myeloma. After undergoing treatment for the same, the patient was seen a year later and noted to have significant resolution of the macular edema and subretinal fluid in both eyes. Conclusion: In patients who suffer with atypical macular edema that is resistant to conventional treatment, it is imperative to look for underlying systemic illnesses such as immunoproliferative disorders and hematologic malignancies.

Keywords: Atypical Macular Edema, Multiple Myeloma, Paraproteinemic Maculopathy, Serous Macular Detachment

1. Coscas G, editor. Macular edema. 2nd, revised and extended edition. In: Bandello F, editor Developments in ophthalmology. Volume 58. Basel: Karger; 2017. p. 102–138.

2. Bandello F, Battaglia Parodi M, Lanzetta P, Loewenstein A, Massin P, Menchini F, et al. Diabetic macular edema. Dev Ophthalmol 2017;58:102–38.

3. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999;127:688–693.

4. Hikichi T, Ohtsuka H, Higuchi M, Matsushita T, Ariga H, Kosaka S, et al. Causes of macular serous retinal detachments in Japanese patients 40 years and older. Retina 2009;29:395–404.

5. lanary WE, Meirick TM, Boldt HC. Waldenstrom macroglobulinema-associated retinopathy. EyeRounds.org; 2015.

6. Wilkinson CP, Ferris FL 3rd , Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677–1682.

7. Mansour AM, Arevalo JF, Badal J, Moorthy RS, Shah GK, Zegarra H, et al. Paraproteinemic maculopathy. Ophthalmology 2014;121:1925–1932.

8. Baker PS, Garg SJ, Fineman MS, Chiang A, Alshareef RA, Belmont J, et al. Serous macular detachment in Waldenström macroglobulinemia: A report of four cases. Am J Ophthalmol 2013;155:448–455.

9. Besirli CG, Johnson MW. Immunogammopathy maculopathy associated with Waldenström macroglobulinemia is refractory to conventional interventions for macular edema. Retin Cases Brief Rep 2013;7:319–324.

10. Lin CJ, Chiu YM, Chen SN, Hwang JF, Hu PS. Unusual maculopathy secondary to hypergammaglobulinemia in a patient with systemic lupus erythematosus. Retin Cases Brief Rep 2012;6:27–29.

11. Berta A, Beck P, Mikita J. IgM paraprotein in the subretinal fluid of a patient with recurrent retinal detachment and Waldenström’s macroglobulinaemia. Acta Med Hung 1985;42:179–186.

12. Menke MN, Feke GT, McMeel JW, Treon SP. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom’s macroglobulinemia. Invest Ophthalmol Vis Sci 2008;49:1157–1160.

13. Georgakopoulos CD, Plotas P, Angelakis A, Kagkelaris K, Tzouvara E, Makri OE. Dexamethasone implant for immunogammopathy maculopathy associated with IgA multiple myeloma. Ther Adv Ophthalmol 2019;11:2515841418820441.

14. Krishnappa NC, Ganne P. Paraproteinemic maculopathy in a 63-year-old man. JAMA Ophthalmol 2018;136:944–945.